Test Price
2,400 AED✅ Home Collection Available
Microarray 315K+ with Single Karyotyping – Prenatal & Postnatal Chromosomal Analysis in UAE | 2,400 AED | DHA-Licensed
Executive Summary & Core Metrics
Test Overview & Methodology
This high-resolution genomic test screens the entire genome for submicroscopic chromosomal imbalances using a 315,000-marker single-nucleotide polymorphism (SNP) microarray, delivering precise copy-number detection for prenatal and postnatal diagnosis of genetic disorders. Results are available within 7–9 days. A physician prescription is required prior to sample collection.
| Parameter | Our Test (315K+ Microarray + Karyotyping) | Conventional Karyotyping (G-Band) |
|---|---|---|
| Resolution | Detects CNVs ≥200 kb; 315K+ SNP markers | Limited to 5–10 Mb; ~450–550 bands |
| Method | Affymetrix CytoScan Optima SNP array + cell culture & karyotype integration | Giemsa banding microscopy |
| Turnaround | 7–9 days | 10–14 days |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403), advises: “While the 315K+ SNP microarray can identify pathogenic copy-number variants with high sensitivity, results must always be interpreted within the full context of clinical presentation and family history. Our genetic counsellors are available to guide you through the implications of any findings and to recommend appropriate follow-up.”
Exclusion Criteria & Red Flags
- Insufficient sample volume or degraded DNA prevents accurate analysis.
- After amniocentesis or CVS: seek immediate medical attention for contractions, vaginal bleeding, fluid leakage, or reduced fetal movement.
- This genomic test is not a substitute for urgent clinical assessment — contact your obstetrician or visit the emergency department if concerning symptoms develop.
Medication Advisory
Do not discontinue any prescribed medication without prior consultation with your treating physician. Some medications may influence metabolic pathways and should be managed under medical supervision during the testing period.
Patient FAQ & Clinical Guidance
1. What conditions can this test detect?
This microarray detects chromosomal microdeletions, duplications, and uniparental disomy linked to developmental delay, congenital anomalies, and autism spectrum disorders. The SNP platform scans over 315,000 markers to uncover submicroscopic imbalances that standard karyotyping misses, including well-known syndromes such as DiGeorge, Prader-Willi, and Angelman. It can also identify susceptibility loci for neurodevelopmental disorders, enabling early intervention and informed family counselling.
2. How is the sample collected and what safety measures are in place?
Sample collection for prenatal microarray requires an invasive procedure — amniocentesis, chorionic villus sampling (CVS), or cord blood draw — performed by a qualified obstetrician under continuous ultrasound guidance to minimise risk. Postnatal testing uses a standard peripheral blood draw. All procedures take place within an accredited hospital setting; mobile home phlebotomy is not available for this test. Clinical protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and informed consent are strictly maintained.
3. When will I receive my results and how are they interpreted?
Results are delivered within 7–9 days in a comprehensive report that includes clinical interpretation and a dedicated telephonic consultation with a genetic counsellor. The report details any pathogenic or uncertain copy-number variants, mapped to genomic coordinates and cross-referenced with clinical databases. Your counsellor will explain the findings, discuss recurrence risks, and outline recommended next steps. All personal data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with all applicable UAE federal laws governing health data and personal privacy. Patient information is processed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures follow the standards set by Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure patient safety and informed consent. Our laboratory is ISO 9001:2015 certified (INT/EGQ/2509DA/3139), reinforcing our commitment to quality and data security.
Clinical & Logistical Metadata
| Test Name | Microarray 315K+ with Single Karyotyping (Prenatal & Postnatal Chromosomal Analysis) |
| Price (AED) | 2,400 AED |
| Turnaround Time | 7–9 business days |
| Sample Type / Matrix | Amniotic Fluid / Chorionic Villi / Cord Blood / Peripheral Blood – Hospital Extraction Only (mobile home phlebotomy disabled for safety) |
| Methodology Used | SNP Microarray (Affymetrix CytoScan Optima) + Cell Culture Karyotyping Integration |
| ICD-10-CM Code | Z31.5 |
| LOINC Code | 62188-1 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians